EP Patent

EP0616804A1 — Gamma-hydroxybutyric acid salts possessing anxiolytic activity and suitable for the treatment of states of depression

Assigned to Laboratorio Farmaceutico CT SRL · Expires 1994-09-28 · 32y expired

What this patent protects

Use of pharmaceutically acceptable salts of gamma-hydroxybutyric acid as active ingredients for the preparation of pharmaceutical compositions possessing anxiolytic activity and suitable for the treatment of states of depression.

USPTO Abstract

Use of pharmaceutically acceptable salts of gamma-hydroxybutyric acid as active ingredients for the preparation of pharmaceutical compositions possessing anxiolytic activity and suitable for the treatment of states of depression.

Drugs covered by this patent

Patent Metadata

Patent number: EP0616804A1
Jurisdiction: EP
Classification: —
Expires: 1994-09-28
Drug substance claim: No
Drug product claim: No
Assignee: Laboratorio Farmaceutico CT SRL
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.